Automation of the SomaLogic Proteomics Assay: A Platform for Biomarker Discovery
Open Access
- 1 December 2009
- journal article
- Published by SAGE Publications in SLAS Technology
- Vol. 14 (6), 360-366
- https://doi.org/10.1016/j.jala.2009.05.003
Abstract
At SomaLogic, we have embarked on an ambitious program of clinical studies using a novel aptamerbased proteomics technology to discover biomarkers and develop new tools to diagnose, understand, and treat human disease. As part of this program, we designed and implemented an automated assay for its highly multiplexed proteomics discovery platform. The performance of the automated assay was validated in a study that compared the automated assay to the specifications of an established manual method. Results showed that the automated method performed to the required specifications, and that the automation system improved the efficiency, productivity, and economics of our biomarker discovery program.Keywords
This publication has 11 references indexed in Scilit:
- Proteomics Ponders Prime TimeScience, 2008
- Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular ProteomeScience, 2008
- Proteomics and diagnostics: Let's Get Specific, againCurrent Opinion in Chemical Biology, 2008
- Cancer biomarkers: a systems approachNature Biotechnology, 2006
- HTS technologies in biopharmaceutical discoveryDrug Discovery Today, 2006
- Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available databaseProteomics, 2005
- The use of aptamers in large arrays for molecular diagnosticsMolecular Diagnosis, 1999
- Oligonucleotides as Research, Diagnostic, and Therapeutic AgentsJournal of Biological Chemistry, 1995
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990